检索结果-南通市图书馆

第十一次中国生物物理学术大会暨第九届全国会员代表大会

作者： xiao wang,weiguo yang,xiaodong tan,zhongju xiao department of physiology,school of basic medical sciences,southern medical university,guangzhou 510515

＜正＞Neuron discharging is thought to be triggered by a fixed threshold *** auditory system studies,however,what is the neuronal firing threshold has been debated not only in

关键词： first spike latency envelope of tone burst neuron auditory system

来源： cnki会议评论

在线全文

cnki会议

学校读者我要写书评

暂无评论

Temporal Integration of Sound Intensity Determines the Firing Threshold of an Inferior Collicular Neuron in Mice

引用

生物物理学报 2009年第S1期25卷 42-42页

作者： xiao wang, weiguo yang, xiaodong tan, zhongju xiao department of physiology, school of basic medical sciences, southern medical university, guangzhou 510515

Neuron discharging is thought to be triggered by a fixed threshold reached. In auditory system studies, however, what is the neuronal firing threshold has been debated not only

关键词： first spike latency envelope of tone burst neuron auditory system

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

A ribosomal gene panel predicting a novel synthetic lethality in non-BRCAness tumors

引用

Signal Transduction and Targeted Therapy 2023年第6期8卷 3070-3086页

作者： Chao Zhang Qiang Guo Lifeng Chen Zheming Wu xiao-Jian Yan Chengyang Zou Qiuxue Zhang Jiahong tan Tian Fang Qunxian Rao yang Li Shizhen Shen Min Deng Liewei wang Huanyao Gao Jia Yu Hu Li Cheng Zhang Somaira Nowsheen Jake Kloeber Fei Zhao Ping Yin Chunbo Teng Zhongqiu Lin Kun Song Shuzhong Yao Liangqing Yao Lingying Wu Yong Zhang xiaodong Cheng Qinglei Gao Jian Yuan Zhenkun Lou Jin-San Zhang Beijing Institute of basic medical sciences 100850BeijingChina department of Oncology Mayo ClinicRochesterMN55905USA school of Pharmaceutical sciences Wenzhou Medical University325035WenzhouZhejiangChina Key Laboratory of Endocrine Gland Diseases of Zhejiang Province Zhejiang Provincial People’s Hospital310014HangzhouZhejiangChina department of Gynecology Zhejiang Provincial People’s Hospital310014HangzhouZhejiangChina department of Gynecology the First Affiliated Hospital of Wenzhou Medical University325000WenzhouZhejiangChina Wuhan Kingwise Biotechnology Co. Ltd.430206WuhanHubeiChina Cancer Biology Research Center(Key Laboratory of the Ministry of Education) Tongji HospitalTongji Medical CollegeHuazhong University of Science and Technology430030WuhanHubeiChina department of Gynecological Oncology Sun Yat-sen Memorial HospitalSun Yat-sen University510120GuangzhouGuangdongChina Zhejiang Provincial Key Laboratory of Traditional Chinese Medicine for Reproductive Health Research 310006HangzhouZhejiangChina Zhejiang Provincial Key Laboratory of Precision Diagnosis and Therapy for Major Gynecological Diseases 310006HangzhouZhejiangChina department of Molecular Pharmacology and Experimental Therapeutics Mayo ClinicRochesterMN55905USA department of Dermatology University of California San DiegoSan DiegoCA92122USA Key Laboratory of Saline-alkali Vegetation Ecology Restoration Ministry of EducationCollege of Life ScienceNortheast Forestry University150040HarbinChina Division of Gynecology Oncology Department of Obstetrics and GynecologyQilu HospitalShandong University250012JinanShandongChina department of Obstetrics and Gynecology the First Affiliated HospitalSun Yat-Sen University510080GuangzhouGuangdongChina department of Gynecologic Oncology Obstetrics and Gynecology Hospital of Fudan University200090ShanghaiChina department of Gynecologic Oncology National Cancer Center/National Clinical Research Center for Cancer/Cancer HospitalChinese Academy of

Poly(ADP-ribose)polymerase(PARP)inhibitors are one of the most exciting classes of targeted therapy agents for cancers with homologous recombination(HR)***,many patients without apparent HR defects also respond well to PARP inhibitors/*** biomarker responsible for this mechanism remains ***,we identified a set of ribosomal genes that predict response to PARP inhibitors/cisplatin in HR-proficient *** inhibitor/cisplatin selectively eliminates cells with high expression of the eight genes in the identified panel via DNA damage(ATM)signaling-induced pro-apoptotic ribosomal stress,which along with ATM signaling-induced pro-survival HR repair constitutes a new model to balance the cell fate in response to DNA ***,the combined examination of the gene panel along with HR status would allow for more precise predictions of clinical response to PARP inhibitor/*** gene panel as an independent biomarker was validated by multiple published clinical datasets,as well as by an ovarian cancer organoids library we *** importantly,its predictive value was further verified in a cohort of PARP inhibitor-treated ovarian cancer patients with both RNA-seq and WGS ***,we identified several marketed drugs capable of upregulating the expression of the genes in the panel without causing HR deficiency in PARP inhibitor/cisplatin-resistant cell *** drugs enhance PARP inhibitor/cisplatin sensitivity in both intrinsically resistant organoids and cell lines with acquired ***,our study identifies a marker gene panel for HR-proficient patients and reveals a broader application of PARP inhibitor/cisplatin in cancer therapy.

关键词： drugs BRCA panel

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

同步放化疗60 Gy对比50 Gy剂量治疗不可手术食管鳞状细胞癌的多中心随机对照研究

引用

中华医学杂志 2020年第23期100卷 1783-1788页

作者：徐裕金朱卫国 Liao Zhongxing 孔月王万伟李建成黄荣何瀚杨新妹刘利萍孙宗文何慧娟包勇曾铭濮娟胡望远马军江浩刘志刚庄婷婷谭榜宪杜向慧裘国勤周霞季永领胡晓王谨马红莲郑晓黄瑾刘安文梁晓东陶华周菊英刘源陈明中国科学院肿瘤与基础医学研究所中国科学院大学附属肿瘤医院浙江省肿瘤医院胸部放疗科杭州310022 淮安市第一人民医院放疗科淮安223300 department of Radiation Oncology University of TaxesM.D.Anderson Cancer CenterHouston 77030the United States 福建省肿瘤医院胸部放疗科福州350014 佛山市第一人民医院放疗科佛山528000 嘉兴市第一人民医院肿瘤内科嘉兴314000 济宁市第一人民医院肿瘤科济宁272011 衢州市人民医院放疗科衢州324000 中山大学附属肿瘤医院放疗科广州510080 四川省人民医院放疗科成都610072 涟水市人民医院放疗科涟水223400 金华市中心医院放疗科金华321000 安徽省立医院放疗科合肥230001 蚌埠医学院第一附属医院放疗科蚌埠233004 湖南省肿瘤医院放疗科长沙410013 汕头大学医学院附属肿瘤医院放疗科汕头515031 川北医学院附属医院放疗科南充637000 常州市第一人民医院放疗科常州213003 南昌大学附属第二医院放疗科南昌330006 浙江省人民医院放疗科杭州310014 江苏省肿瘤医院放疗科南京210009 苏州大学附属第一医院放疗科苏州215006 广州医科大学附属肿瘤医院放疗科广州510095 中山大学附属第一医院放疗科中山大学附属第五医院肿瘤中心

目的采用调强放疗(IMRT)技术进行食管鳞状细胞癌同步放化疗,比较60 Gy的放疗剂量是否优于国际标准的50 Gy。方法2013年4月至2017年5月将来自22家医院的331例经病理证实的无法手术的ⅡA~ⅣA期食管鳞状细胞癌患者以随机数字表法分为60 Gy... 详细信息

目的采用调强放疗(IMRT)技术进行食管鳞状细胞癌同步放化疗,比较60 Gy的放疗剂量是否优于国际标准的50 Gy。方法2013年4月至2017年5月将来自22家医院的331例经病理证实的无法手术的ⅡA~ⅣA期食管鳞状细胞癌患者以随机数字表法分为60 Gy和50 Gy两组接受放疗。最后纳入可分析病例305例,其中60 Gy组152例,50 Gy组153例。中位年龄63岁,男242例(79.3%),女63例(20.7%)。原发灶中位长度5.6 cm。两组基础资料具有可比性。所有患者放疗2 Gy/次,每周5次。同步化疗5周,每周1次:多西紫杉醇(25 mg/m2)+顺铂(25 mg/m2);巩固化疗2周期,3周重复:多西紫杉醇(70 mg/m2),d1+顺铂(25 mg/m2),d1~3。首要研究终点为局部区域无进展生存期(LRPFS)。两组分类变量比较采用Pearsonχ^2检验或Fisher精确检验。结果中位随访27.3个月,60 Gy组疾病进展率为37.5%(57/152),50 Gy组为43.8%(67/153),组间差异无统计学意义(χ^2=1.251,P=0.263)。60 Gy组和50 Gy组1、2、3年LRPFS分别为75.4%、56.8%、52.1%和74.2%、58.4%、50.1%(HR:0.95,95%CI:0.69~1.31,P=0.761)。两组1、2、3年总生存率分别为84.1%、64.8%、54.1%和85.4%、62.9%、54.0%(HR:0.98,95%CI:0.71~1.38,P=0.927)。两组1、2、3年无进展生存分别为70.8%、54.2%、48.5%和65.5%、51.9%、45.1%(HR:0.93,95%CI:0.68~1.26,P=0.621)。60 Gy组3级以上肺炎发生率为7.2%,50 Gy组为3.3%,组间差异有统计学意义(χ^2=11.596,P=0.021),其他毒副作用两组相似。结论同步放化疗模式治疗食管癌,50 Gy与60 Gy的疗效无差异,推荐50 Gy为常用放疗剂量。

关键词：食管肿瘤鳞状细胞癌放射治疗放射剂量预后

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：